| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 18.529 | 92.826 | 159.701 | 198.246 | 193.945 |
| Total Income - EUR | - | - | - | - | - | 18.529 | 92.826 | 159.701 | 199.892 | 193.945 |
| Total Expenses - EUR | - | - | - | - | - | 13.898 | 20.340 | 38.586 | 90.662 | 85.221 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 4.631 | 72.486 | 121.115 | 109.230 | 108.724 |
| Net Profit/Loss - EUR | - | - | - | - | - | 4.100 | 70.036 | 119.757 | 107.531 | 92.395 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Newfast Implant S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 2.894 | 2.283 | 1.793 | 1.492 | 3.868 |
| Current Assets | - | - | - | - | - | 1.557 | 71.973 | 120.699 | 159.163 | 138.032 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 3.748 |
| Receivables | - | - | - | - | - | 0 | 0 | 92.993 | 16.475 | 91.721 |
| Cash | - | - | - | - | - | 1.557 | 71.973 | 27.706 | 142.689 | 42.563 |
| Shareholders Funds | - | - | - | - | - | 4.141 | 71.535 | 121.834 | 148.130 | 120.683 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 311 | 2.720 | 658 | 12.525 | 21.217 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Newfast Implant S.r.l.